- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.12. | A single mutation could make H5N1 flu a human threat | ||
| 06.12. | Insulin pump firm Insulet wins $452m in trade secrets clash | ||
| 06.12. | Atlas closes $450m biotech fund, and other financing news | ||
| 05.12. | FDA clears AZ's Imfinzi for aggressive lung cancer | ||
| 05.12. | Merus grabs first-in-class US approval for NRG1 cancer drug | ||
| 05.12. | Novartis bid to block generic Entresto in US suffers setback | ||
| 05.12. | Mounjaro cleared for NHS use, but patients may have to wait | ||
| 05.12. | Still no clear motive in UnitedHealth CEO killing | ||
| 04.12. | Genmab expands its pipeline with $630m Scancell deal | ||
| 04.12. | Zepbound tops Wegovy in first head-to-head weight-loss trial | ||
| 04.12. | UK orders 5 million bird flu jabs for pandemic preparedness | ||
| 04.12. | MHRA's stature undermined by lack of resources says pharma | ||
| 04.12. | Warning letter adds to Applied Tx run of bad news | ||
| 03.12. | Gilead looks beyond Trodelvy with Tubulis alliance | ||
| 03.12. | FDA kicks off review of Cytokinetics' aficamten for HCM | ||
| 03.12. | Ipsen doubles up in TCEs for cancer, adding Biomunex drug | ||
| 03.12. | Deadline looms for post-Brexit label changes for UK meds | ||
| 03.12. | Immunocore's rare eye cancer drug backed by NICE | ||
| 02.12. | Novartis pays $1bn upfront for Huntington's drug from PTC | ||
| 02.12. | BMS files legal challenge to HHS' 340B rebate decision | ||
| 02.12. | Orexo exits depression DTx alliance with GAIA | ||
| 02.12. | Alligator slashes workforce and pares down its pipeline | ||
| 02.12. | Abingworth 'will launch $1.5bn fund for co-developed drugs' | ||
| 29.11. | Adcendo raises $135m for cancer ADCs, and other financings | ||
| 29.11. | Sanofi opens $595m manufacturing facility in Singapore |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
